Previous close | 372.00 |
Open | 374.65 |
Bid | 375.95 x 200 |
Ask | 377.14 x 100 |
Day's range | 370.85 - 381.79 |
52-week range | 189.30 - 419.42 |
Volume | |
Avg. volume | 259,872 |
Market cap | 11.658B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 42.42 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Strong Performance Driven by Increased Revenue and Efficient Backlog Conversion
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The Strategy underperformed the benchmark in the quarter. The small-cap growth universe revealed a stark dichotomy despite the positive performance of the benchmark Russell 2000 Growth Index, which […]
Key Insights Medpace Holdings' estimated fair value is US$376 based on 2 Stage Free Cash Flow to Equity Current share...